276 related articles for article (PubMed ID: 8730499)
1. Hepatitis C antibody and cryoglobulins in patients with cirrhosis and hepatocellular carcinoma.
Rinaldi G; Saccardo F; Petrozzino MR; Bossi E; Manna MR; Monti G
Clin Exp Rheumatol; 1995; 13 Suppl 13():S161-3. PubMed ID: 8730499
[TBL] [Abstract][Full Text] [Related]
2. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
3. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
5. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
[TBL] [Abstract][Full Text] [Related]
6. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
11. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil.
Alencar RS; Gomes MM; Sitnik R; Pinho JR; Malta FM; Mello IM; Mello ES; Bacchella T; Machado MC; Alves VA; Carrilho FJ
Braz J Med Biol Res; 2008 Mar; 41(3):235-40. PubMed ID: 18097499
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.
Caporaso N; Romano M; Marmo R; de Sio I; Morisco F; Minerva A; Coltorti M
J Hepatol; 1991 May; 12(3):367-71. PubMed ID: 1658121
[TBL] [Abstract][Full Text] [Related]
13. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
17. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma. A case control study.
Goritsas CP; Athanasiadou A; Arvaniti A; Lampropoulou-Karatza C
J Clin Gastroenterol; 1995 Apr; 20(3):220-4. PubMed ID: 7797831
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
Li HK; Qin Y; Li XM; Li Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
[TBL] [Abstract][Full Text] [Related]
20. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]